Clinical Trial Update: IMA910 Plus GM-CSF With Low-dose Cyclophosphamide Pre-treatment in Advanced Colorectal Carcinoma Patients Following a Successful 12 Week First-line Treatment With Oxaliplatin-based Chemotherapy (IMA910-101) [Phase 1, Phase 2]

View source ↗

Summary

An update on the Phase 1/Phase 2 trial IMA910-101 evaluating IMA910 with GM-CSF and low-dose cyclophosphamide pre-treatment in advanced colorectal cancer patien…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• GM-CSF (granulocyte-macrophage colony-stimulating factor)
• IMA910

Snippet

Sponsor: Immatics Biotechnologies GmbH | Conditions: Colorectal Carcinoma | Phase 1, Phase 2 | Status: COMPLETED